Siga Technologies (United States)
SIGA Technologies, Inc. is an American pharmaceutical company founded in 1995, based in New York City, which develops and sells pharmaceutical solutions for the antiviral treatment of smallpox, monkeypox, cowpox, and vaccinia complications. Derived from Wikipedia licensed CC-BY-SA.
Open Access statistics for Siga Technologies (United States), United States, covering academic research published from 2000 to 2024. Read More.
Open Access Percentage
66%
Total
Publications
127
Total Open
Publications
84
Total
Citations
6.5K
Open Access
Percentage
66%
Total
Publications
127
Total Open
Publications
84
Total
Citations
6.5K
Breakdown
Publisher Open
8%
Both
42%
Other Platform Open
17%
Closed
33%
Percentage of Open Access over time
Publisher Open
Both
Other Platform Open
Closed
Volume of Open Access over time
Open
Closed
Publisher Open
OA Journal 60%
38
Hybrid 6%
4
No Guarantees 34%
22
Other Platform Open
Domain 61%
46
Other Internet 39%
30
Institution 5%
4
Preprint 3%
2
Public 0%
0
Other Platform Locations
Name | Platform Type | Publications |
|---|---|---|
PubMed Central | Domain | 47 |
DOI | Other Internet | 30 |
Europe PMC | Domain | 3 |
bioRxiv | Preprint | 2 |
University of Oxford | Institution | 1 |
University of Michigan–Ann Arbor | Institution | 1 |
Universitat Autònoma de Barcelona | Institution | 1 |
Office of Scientific and Technical Information | Institution | 1 |